Earnings call transcript: Unipar’s Q4 2025 results show EBITDA growth

Unipar reported FY2025 adjusted recurring EBITDA up 16% YoY to BRL 1.109bn with EBITDA margin rising to 22% (from 19%), net income BRL 482m and operating cash generation BRL 1.248bn; capex was BRL 1.1bn (largest cycle in company history). Q4 recurring EBITDA fell 32% QoQ to BRL 182m due to seasonal effects and international price declines (PVC and soda), with BRL 39m of non‑recurring charges and an impairment on PVC inventory. Balance sheet strength: year‑end cash BRL 1.78bn (covers 26 months of amortization), net leverage ~2.2x, and stock fell 2.4% to BRL 2.92 (P/E ~7.19; 52‑week range BRL 2.82–4.95); management highlighted cost cuts (BRL 67m, −5%) and operational upgrades (membrane tech, renewables) that should support margins going forward.

Analysis

A chemical-player exposed to both petrochemical cyclicality and a growing clorados/municipal water-exposure has asymmetric outcomes versus pure PVC-focused peers. Lower energy intensity and localized supply advantages translate into higher realized margins when global PVC supply tightens or freight dislocations raise landed costs of imports; conversely, sustained import competition or a stronger feedstock-cost currency channel will compress spreads first.

Two important second-order vectors to monitor are (1) the upstream ethylene/nafta indexing and its pass-through cadence into domestic PVC contracts, which creates a lagged earnings shock if feedstock costs spike faster than domestic contract resets; and (2) working-capital timing around inventory impairments — write-downs today can become re-rating catalysts if spot PVC recovers, turning a non-cash hit into an earnings tailwind. Both operate on multi-month horizons and can flip sentiment quickly.

From a capital-allocation angle, an investor should value a transition from heavy investment to cash generation as optionality for either accelerated deleveraging, special distributions, or opportunistic M&A in regional consolidation. The market tends to over-penalize near-term seasonal softness; a 6–18 month view that prices in normalization of PVC markets and sustained demand from sanitation/agronegocio is a pragmatic way to capture upside while respecting cyclical downside.

Key Decisions for Investors

• Long AUAU3 (Unipar): buy tranche at market with a 6–12 month horizon. Size 3–5% portfolio, set stop-loss at ~15% below entry, target a 40–70% upside driven by re-rating and inventory reversals. Hedge execution risk by selling short a PVC-exposed peer (e.g., BRKM5) equal to 30% of notional long to isolate clorados vs PVC exposure.
• Pair trade: long AUAU3 / short BRKM5 — execute equal notional positions with monthly rebalancing. Thesis: capture differential if chlorine/caustic outperform PVC during regional demand improvement; time horizon 3–9 months. Close if spread narrows by 50% or if PVC import volumes fall >20% YoY (monitor customs data).
• Options hedge: buy 9–12 month AUAU3 out‑of‑the‑money calls (delta ~0.25) financed by selling nearer-term calls to reduce cost. Rationale: asymmetric upside to rerating from inventory reversals and improved spreads while capping premium outlay. Exit or roll if implied volatility compresses >30% or on positive quarterly surprises.